By Jessica Hall and Susan Kelly PHILADELPHIA/CHICAGO (Reuters) - The board of Guidant Corp. ( GDT.N: , , ), the target of a bidding war between Johnson & Johnson (JNJ.N: , , ) and Boston Scientific Corp. (
http://c.moreover.com/click/here.pl?r452115402
http://c.moreover.com/click/here.pl?r452115402